Outsourcing Pharma

JULY 14, 2021

The two companies will work together to come up with solutions that use machine learning and artificial intelligence to help accelerate innovation in R&D.

141

141

pharmaphorum

JULY 13, 2021

Faced with a looming mental health crisis, the UK government has been urged to invest in the digitisation of service provision across the NHS in England in a new report from think tank Future Care Capital. The study’s author – FCC’s head of policy and research Dr Peter Bloomfield, argues that there has been a lack of support for mental health services for many years in the UK, and the pathways for accessing them are “convoluted, waiting lists are extensive, and outcomes are po

Documentation 124

Documentation 124

Pharma Marketing Network

JULY 16, 2021

Hear from leading Experience and Omnichannel experts from Merck , AstraZeneca , UCB , AbbVie , Harmony Biosciences , Genentech and more on winning strategies to transform data into actionable strategy, elevate CX beyond campaign optimization and activate the “Engagement Matrix” in your organization. Panel discussions include: Coordinated CX: Moving Beyond Campaign Management.

59

59

NICE

JULY 16, 2021

As the regulatory and access system for drugs, medical technologies, diagnostics, and digital health technologies continues to evolve at pace, it can be challenging for companies to keep up with the latest developments. Therefore, more companies from the life sciences industry are prioritising early engagement with NICE to ensure they are focussing on the right areas in their evidence generation strategies.

52

52

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Outsourcing Pharma

JULY 12, 2021

Antibody responses against the SARS-CoV-2 spike protein were found in 99% of volunteers after the second dose of ReiTheraâs COVID-19 vaccine candidate, according to Phase 2 preliminary data.

Vaccines 105

Vaccines 105

pharmaphorum

JULY 15, 2021

The UK’s competition authority has issued its largest ever fine of more than £260 million ($360 million) to several pharma companies accused of colluding to hike the price of medicines delivered to the NHS. The Competition and Markets Authority (CMA) took the action against Auden Mckenzie and Actavis UK – now known as Accord-UK – and other companies after an investigation into the price of hydrocortisone tablets, which rose by 10,000% over a 10-year period.

Patient Care 119

Patient Care 119

Pharma Mirror

JULY 15, 2021

Alcohol abuse is closely correlated with depression. This doesn’t necessarily mean one causes the other, but many people who suffer from depressive disorders turn to alcohol to escape. On the other side of that coin, those who abuse or overuse alcohol can develop symptoms of depression or exacerbate symptoms that are already present. So, how are these two issues related, and how can you help a loved one if you start to notice alcohol-induced depression or depression-induced alcohol abuse?

52

52

Outsourcing Pharma

JULY 15, 2021

Eli Lilly and Company and Banner Alzheimerâs Institute have announced a strategic research collaboration as part of the planned Phase 3 study for donanemab in participants at risk from cognitive and functional decline related to Alzheimerâs disease.

98

98

pharmaphorum

JULY 14, 2021

AstraZeneca and Johnson & Johnson are both exploring ways to modify their COVID-19 vaccines to minimise the risk of severe blood clotting reactions that are seen – albeit rarely – in some people receiving the jabs. At the same time, the UK’s National Institute for Health and Care excellence (NICE) is developing guidance to help doctors manage the cases of vaccine-induced immune thrombocytopenia and thrombosis (VITT) and low blood platelet counts that have been seen with the COVID-19 va

Vaccines 116

Vaccines Immunization 116

Pharma Marketing Network

JULY 16, 2021

This content is password protected. To view it please enter your password below: Password: The post Protected: PMN 2021 Summer Summit: Evolving the Customer Experience appeared first on Pharma Marketing Network.

52

52

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

The Nontraditional Pharmacist

JULY 11, 2021

Dr. Lorece Shaw shares her story as a prior authorization specialist – a job she works at 100% remotely. She discusses the path to her role, work/life balance, and offers advice for those interested in following a similar career. Name : Lorece Shaw. Title : Prior Authorization Pharmacist. The post Remote Work as a Prior Authorization Specialist appeared first on The Nontraditional Pharmacist.

52

52

Outsourcing Pharma

JULY 14, 2021

A representative from the medication management solutions company suggests patient behavior data can be used to improve adherence to trial drug regimens.

98

98

pharmaphorum

JULY 14, 2021

In this episode of Health Innovators , pharmaphorum founder Paul Tunnah interviews Jo Brewer, senior vice president of allogeneic research at UK company Adaptimmune which is transforming cancer immunotherapy with affinity enhanced T-cell receptors. Adaptimmune’s SPEAR (Specific Peptide Enhanced Affinity Receptor) T-cell platform enables the engineering of T-cells to target and destroy cancer across multiple solid tumors.

Communication 111

Communication 111

Pharma Marketing Network

JULY 13, 2021

The PharmaMarketing Summit provides a platform that helps America’s pharmaceutical marketing executives evaluate and partner with relevant suppliers and service providers, while we connect pharmaceutical companies with these senior forward-thinking marketing executives. THE EXECUTIVES. Senior Pharmaceutical Marketing Executives Representing Americas Foremost Pharmaceutical Companies.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharma Times

JULY 13, 2021

In 2020, the two partners announced an initial collaboration to integrate Cegedim’s ‘THIN’ European real-world data into Aetion’s evidence platform

55

55

Outsourcing Pharma

JULY 13, 2021

The genetic exome sequence analysis partnership has created a large database linking rare protein-coding genetic variants to human health and disease.

98

98

pharmaphorum

JULY 13, 2021

Diagnosing Alzheimer’s disease is still a challenge, particularly in its earliest stages, but a new study suggests that subtle changes in behaviour whilst driving could serve as an early warning system. The researchers used GPS logging devices and machine learning as “digital biomarkers” to compare the driving of people who have preclinical Alzheimer’s but are still cognitively normal to a control group of normal age-matched drivers over the course of a year.

Insurance 111

Insurance 111

Med Ed 101

JULY 14, 2021

You’ve likely encountered numerous patients with hyperglycemia. A challenging situation that often comes up in practice is the loss of blood sugar control from a patient who had previously been well controlled. Your first step would be to inquire about adherence. What else should you consider? I always consider looking at possible drugs that cause […].

40

40

Pharma Times

JULY 13, 2021

Researchers discover presence of 'autoantibodies' in people with persistent COVID-19 symptoms

72

72

Outsourcing Pharma

JULY 14, 2021

A leader from the clinical tech consultancy shares advice on how to employ training to help keep up with the rapidly evolving field of data management.

80

80

pharmaphorum

JULY 14, 2021

James Dempsey breaks down the misconception that culture can’t be measured, and gives tips for how companies can implement a clear culture strategy. In 2014, six years after the global financial crisis forced the world’s biggest financial institutions into some serious navel gazing, the CEO of a major international bank was despairing: “We’ve put in place a best-in-class compliance system, but we can’t stop our people acting badly.

Pharmaceutical Companies 105

Pharmaceutical Companies Pharmaceutical Companies Communication Vaccines 105

Med Ed 101

JULY 11, 2021

Ivermectin and hydroxychloroquine have been purported as potential COVID treatments. We break down where these drugs stand in regards to those claims. The NIH COVID-19 Treatment Guidelines Panel have recommended against any use of chloroquine or hydroxychloroquine (HCQ) for the treatment of COVID-19, including concomitantly with azithromycin. At this point in the pandemic, there has […].

40

40

Pharma Times

JULY 12, 2021

Vaccine effectiveness against symptomatic disease in at-risk groups is approximately 60% after one dose of either the AZ or Pfizer/BioNTech vaccines

Vaccines 53

Vaccines 53

Outsourcing Pharma

JULY 15, 2021

The past several days have seen a relatively large number of industry acqusitions, with Lilly, Phillip Morris, WCG, CTI and others making notable buys.

59

59

pharmaphorum

JULY 12, 2021

A diagnostic test to detect long COVID could be available within six to 12 months, following the discovery that patients with the chronic condition have distinctive antibodies in their blood. . Researchers at Imperial College London (ICL) led by Professor Danny Altmann told the BBC’s Panorama programme that they have identified a pattern of antibodies in people with long COVID different from those who have fully recovered from COVID-19.

Immunization 105

Immunization Vaccines 105

The Infectious Pharmacist

JULY 12, 2021

Photo by David Buchi on Pexels.com. Boy, it has been awhile. I’m sorry it’s taken me so long to write. Frankly I’m sick of this pandemic; surely you are as well. (Your response: I am sick of this pandemic, and don’t call me Shirley.) . Seriously though, I’ve received a number of requests lately to give my take on the COVID-19 Delta variant and frankly, as one reader said, she needed my blog to calm her down.

Vaccines 52

Vaccines Hospitals Immunization 52

Pharma Times

JULY 12, 2021

NICE concluded the cost-effectiveness estimates for Libmeldy are unlikely to be within the range that it would consider an effective use of NHS resources

51

51

Outsourcing Pharma

JULY 12, 2021

Acting US FDA commissioner, Janet Woodcock, has called for an independent federal review of interactions between officials at her agency and representatives of Biogen, prior to the recent approval of the pharma companyâs treatment for Alzheimerâs disease.

FDA 52

FDA 52

pharmaphorum

JULY 15, 2021

Radiotherapy specialist Elekta has joined forces with two academic groups in the Netherlands to explore the use of artificial intelligence (AI) to deliver more effective personalised therapy to patients. . The Swedish company will collaborate with scientists at the Netherlands Cancer Institute and University of Amsterdam (UvA) on a project that aims to use AI to improve the quality of imaging used to direct radiotherapy and guide the delivery of treatment.

98

98

pharmaphorum

JULY 15, 2021

An experimental artificial heart developed by French medical device specialist CARMAT has been implanted into the first of 10 subjects due to be enrolled in a US trial. The Aeson bioprosthetic device has already been implanted in a number of European patients with end-stage biventricular heart failure – affecting both sides of the heart – and shown that it can keep them alive for months, even after they have been sent home for hospital.

Hospitals 98

Hospitals 98

pharmaphorum

JULY 14, 2021

Eli Lilly bought a stake in Protomer Technologies and its glucose-sensing insulin platform last year, and it must like what it has seen in the programme since then – it has just agreed to buy the company outright. . Pasadena, California-based Protomer is working on proteins that can sense molecular activators in the body and only become activated when needed.

98

98

pharmaphorum

JULY 13, 2021

Diabetes giant Novo Nordisk has opened a new front in its rare disease R&D, thanks to an acquisition agreement with Prothena focusing on drugs for ATTR amyloidosis. The Danish drugmaker is paying $100 million upfront for rights to antibody drug PRX004, which is heading for phase 2 trials in cardiomyopathy associated with ATTR amyloidosis, a life-threatening disease affecting the heart and nervous system.

FDA 98

FDA 98

pharmaphorum

JULY 12, 2021

Bayer’s big investment in time and money on the development of finerenone for chronic kidney disease (CKD) in diabetics has paid off with an FDA approval, although it could face stiff competition in the market. . The oral, non-steroidal mineralocorticoid receptor (MR) antagonist has been approved as Kerendia in the US – its first world market – to reduce the risk of kidney function decline, kidney failure, cardiovascular death, non-fatal heart attacks, and hospitalisation for heart failure

FDA 98

FDA 98

pharmaphorum

JULY 16, 2021

French drugmaker Ipsen has made another foray into the Parkinson’s disease category, licensing rights to an oral dopamine D3 receptor antagonist from Sweden’s IRLAB for $28 million upfront. . The deal gives Ipsen worldwide rights to the mid-stage drug – called mesdopetam – and puts the company on the hook for another $335 million in development, regulatory and sales milestones.

89

89